Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Omalizumab (Xolair ® ) for Treatment of Poorly Controlled Asthma

Journal of Asthma & Allergy Educators

Association of Asthma Educators

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Research article

First published online October, 2011

Omalizumab (Xolair ® ) for Treatment of Poorly Controlled Asthma

and

Volume 2, Issue 5

https://doi.org/10.1177/2150129711421198

Abstract

Get full access to this article

View all access options for this article.

References

Cox

Platts-Mills

Finegold

Schwartz

Wallace

; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma and Immunology. American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis. J Allergy Clin Immunol. 2007;120:1373-1377.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

Comparison of Fenoterol and Orciprenaline with regard to Broncho-Dilating Action and β 2 – Selectivity

Restricted access

A Double-Blind Comparative Study with Dolo-Neurobion® and its Separate Constituents in the Treatment of Polyneuritis

Restricted access

2013-2014 Calendar

Restricted access

Pregnancy by Means of Tubal Insemination and Subsequent Spontaneous Pregnancy in Rabbits